Source: ZeroHedge.com
America’s anti-obesity craze, courtesy of GLP-1-based weight-loss drugs such as Wegovy and Mounjaro, produced by Novo Nordisk and Eli Lilly, continues to create anxiety among the food-industrial complex after a new study cited by Morgan Stanley shows households on the weight-loss drugs are spending less at the supermarket.
Market research provider Numerator’s new survey shows households using GLP-1 drugs decreased monthly supermarket spending by 6% to 9% versus non-GLP-1 households.
Many GLP-1 households increased purchases of fish, vegetables, and yogurt while sales of snacks, pastries, and ice cream fell.
MS noted the Numerator survey from January used data from more than 90,000 households, with 12.3% of households indicating they were on GLP-1 drugs, up from 11.4% in October. …